E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress

Diabetologia
L CominaciniV Lo Cascio

Abstract

Although elevated levels of soluble E-selectin and intercellular cell adhesion molecules-1 (ICAM-1) have been reported in non-insulin-dependent diabetes mellitus (NIDDM), it is not clear by what mechanism this elevation occurs and whether or not it is related to glycaemic control. In this study we analyse: 1) the relation of glycaemic control with the concentrations of E-selectin, vascular cell adhesion molecules-1 (VCAM-1) and ICAM-1 in NIDDM patients: 2) whether metabolic control can affect the oxidative stress (as measured by plasma hydroperoxide concentration and susceptibility of LDL to in vitro oxidation) and hence the adhesion molecule plasma concentrations. Thirty-four (19 males and 15 females) poorly controlled NIDDM patients were studied. All parameters were evaluated at the beginning of the study and after 90 days of dietary and pharmacological treatment. The treatment decreased HbA1c (p < 0.001), E-selectin (p < 0.001), plasma hydroperoxides (p < 0.003) and the susceptibility of LDL to in vitro oxidation (lag phase) (p < 0.0001). Before treatment HbA1c, lag phase and lipid hydroperoxides correlated with E-selectin plasma concentration (r = 0.51, -0.57 and 0.54, respectively, p < 0.01). There was also a correlation b...Continue Reading

Citations

Apr 9, 2005·Journal of Thrombosis and Thrombolysis·Shosaku NomuraToshiji Iwasaka
Mar 1, 2005·Metabolism: Clinical and Experimental·Ataru TaniguchiYutaka Seino
Aug 27, 2003·Metabolism: Clinical and Experimental·Geneviève RenierOmar Serri
Aug 11, 2000·Diabetes Research and Clinical Practice·A B Sobol, C Watala
May 16, 2002·Clinical and Experimental Pharmacology & Physiology·Hiroyuki ItoKazuo Nishioka
Feb 13, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·M J SampsonD A Hughes
Apr 25, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·K MatsumotoS Miyake
Mar 21, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·N T MulvihillM Walsh
Oct 3, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·K MatsumotoS Miyake
Jun 15, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Philip C CalderPhilip Newsholme
Apr 20, 2001·Journal of Pediatric Endocrinology & Metabolism : JPEM·N DoğruelT Us
Sep 3, 2013·Antioxidants & Redox Signaling·Manish MittalAsrar B Malik
Jan 25, 2014·Journal of Endocrinological Investigation·M M Roca-RodríguezM Aguilar-Diosdado
May 27, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Antonio CerielloUNKNOWN Guideline Development Group
Jun 25, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·V R SørensenB Feldt-Rasmussen
Jan 29, 2005·International Journal of Cardiology·Mary S BoulbouAnastasios E Germenis
Apr 25, 2006·Journal of Diabetes and Its Complications·Sabita S Soedamah-MuthuUNKNOWN EURODIAB Prospective Complications Study group
Jan 31, 2006·Diabetes Research and Clinical Practice·Dilara SeckinSabahattin Ertugrul
Jul 6, 2016·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Márta KaszaV Nagy
Feb 11, 2010·Journal of Diabetes Science and Technology·Christopher G Parkin, Jaime A Davidson
Jul 13, 2004·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Shosaku NomuraShirou Fukuhara
Jul 18, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·A ShouzuM Inada
Apr 20, 2004·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Shosaku NomuraToshiji Iwasaka
Jul 28, 2017·Food & Function·Jace SchellArpita Basu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.